NeuroTherapeutics Pharma, Inc.
Industry: Biotechnology (See others in industry)
Address:
8750 W. Bryn Mawr Avenue Suite 440
Chicago, IL, 60631
Phone: (773) 444-4180
Chicago, IL, 60631
Phone: (773) 444-4180
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2011-12-21 | New | $12,000,000 | $12,000,000 | Equity Only | 06 | SEC link |
| 2010-05-28 | New | $18,511,530 | $18,511,530 | Equity Only | 06 | SEC link |
| 2009-01-06 | New | $3,200,000 | Unknown | Debt Only | SEC link | |
| 2006-12-15 | Paper Filing | Unknown | Unknown | Other | Not Available |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Thomas R. Beck, M.D. | Director |
| Karen Boezi | Director |
| Jason Brown, Ph.D. | Director |
| Holli A. Carlson | Executive |
| Stephen D. Collins, M.D., Ph.D. | Director, Executive |
| Rajeev Dadoo, Ph.D. | Director |
| Luke Evnin, Ph.D. | Director |
| Corey Goodman, Ph.D. | Director |
| Elaine V. Jones, Ph.D. | Director |
| Heath Lukatch, Ph.D. | Director |
| Phillip F. Morgan, Ph.D. | Director |
| Christine Siu | Director |
| Michael Venuti, Ph.D | Executive |
| Todd Verdoorn, Ph.D. | Executive |
| Stephen P. Wanaski | Executive |
| Stephen P. Wanaski, Ph.D. | Executive |
| Brian B. Williams | Executive |